Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP469091.RAcUfMw4OnL6ZGBfJl0hkQNF_O_R1NB1ST_-c8ACY9kaE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP469091.RAcUfMw4OnL6ZGBfJl0hkQNF_O_R1NB1ST_-c8ACY9kaE130_assertion type Assertion NP469091.RAcUfMw4OnL6ZGBfJl0hkQNF_O_R1NB1ST_-c8ACY9kaE130_head.
- NP469091.RAcUfMw4OnL6ZGBfJl0hkQNF_O_R1NB1ST_-c8ACY9kaE130_assertion description "[This provides a rationale for the therapeutic use of HSP90 inhibitors in myeloid leukemias that contain FGFR fusion proteins.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP469091.RAcUfMw4OnL6ZGBfJl0hkQNF_O_R1NB1ST_-c8ACY9kaE130_provenance.
- NP469091.RAcUfMw4OnL6ZGBfJl0hkQNF_O_R1NB1ST_-c8ACY9kaE130_assertion evidence source_evidence_literature NP469091.RAcUfMw4OnL6ZGBfJl0hkQNF_O_R1NB1ST_-c8ACY9kaE130_provenance.
- NP469091.RAcUfMw4OnL6ZGBfJl0hkQNF_O_R1NB1ST_-c8ACY9kaE130_assertion SIO_000772 21745565 NP469091.RAcUfMw4OnL6ZGBfJl0hkQNF_O_R1NB1ST_-c8ACY9kaE130_provenance.
- NP469091.RAcUfMw4OnL6ZGBfJl0hkQNF_O_R1NB1ST_-c8ACY9kaE130_assertion wasDerivedFrom befree-20150227 NP469091.RAcUfMw4OnL6ZGBfJl0hkQNF_O_R1NB1ST_-c8ACY9kaE130_provenance.
- NP469091.RAcUfMw4OnL6ZGBfJl0hkQNF_O_R1NB1ST_-c8ACY9kaE130_assertion wasGeneratedBy ECO_0000203 NP469091.RAcUfMw4OnL6ZGBfJl0hkQNF_O_R1NB1ST_-c8ACY9kaE130_provenance.